A platform for context-specific genetic engineering of recombinant protein production by CHO cells
•We demonstrate a platform for high-throughput testing of functional genes.•Genetic effectors of the secretory pathway can be used to improve recombinant protein production.•Thorough assessment of gene combinations can lead to greaterimprovements in productivity than single genes alone.•Transient an...
Gespeichert in:
Veröffentlicht in: | Journal of biotechnology 2020-03, Vol.312, p.11-22 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | •We demonstrate a platform for high-throughput testing of functional genes.•Genetic effectors of the secretory pathway can be used to improve recombinant protein production.•Thorough assessment of gene combinations can lead to greaterimprovements in productivity than single genes alone.•Transient and stable production of the same molecule is improved by different genetic effectors.
An increasing number of engineered therapeutic recombinant proteins with unpredictable manufacturability are currently filling industrial cell line development pipelines. These proteins can be “difficult-to-express” (DTE) in that production of a sufficient quantity of correctly processed recombinant product by engineered mammalian cells is difficult to achieve. In these circumstances, identification of appropriate cell engineering strategies to increase yield is difficult as constraints are cell line and product-specific. Here we describe and validate the development of a high-throughput microscale platform for multiparallel testing of multiple functional genetic components at varying stoichiometry followed by assessment of their effect on cell functional performance. The platform was used to compare and identify optimal cell engineering solutions for both transient and stable production of a model DTE IgG1 monoclonal antibody. We simultaneously tested the functional effect of 32 genes encoding discrete ER or secretory pathway components, each at varying levels of expression and utilized in different combinations. We show that optimization of functional gene load and relative stoichiometry is critical and optimal cell engineering solutions for stable and transient production contexts are significantly different. Our analysis indicates that cell engineering workflows should be cell line, protein product and production-process specific; and that next-generation cell engineering technology that enables precise control of the relative expression of multiple functional genetic components is necessary to achieve this. |
---|---|
ISSN: | 0168-1656 1873-4863 |
DOI: | 10.1016/j.jbiotec.2020.02.012 |